CDK4 and neoplasm: Q-PCR of the tumor specimens revealed varying levels of MDM2 and CDK4 amplification, with 44 cases (91.7%) and 46 cases (95.8%) showing positive amplification of CDK4 and MDM2 genes, respectively.